Moderna Stock Stock News Today

MRNA -  USA Stock  

USD 132.06  5.56  4.04%

Moderna Stock News module provides quick insight into current market opportunities from investing in Moderna. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Moderna stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Additionally, see Moderna Hype Analysis, Moderna Correlation and Moderna Performance.
  
Refresh
Moderna stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Moderna daily returns and investor perception about the current pice of Moderna as well as its diversification or hedging effects on your existing portfolios.
3 days ago at www.fool.com         
Better Buy Moderna or Novavax - The Motley Fool
fool News
few days ago at www.fool.com         
Moderna exotic insider transaction detected
fool News
few days ago at www.macroaxis.com         
Moderna exotic insider transaction detected
Macroaxis News
six days ago at www.investors.com         
Vaccine Stocks Pfizer, BioNTech Score A Win Leading Pfizer To Make A Bullish Move - Investors Busine...
Investors Business Daily at Macroaxis
over a week ago at www.macroaxis.com         
Exercise or conversion by Hoge Stephen of 10000 shares of Moderna subject to Rule 16b-3
Macroaxis News
over a week ago at www.nasdaq.com         
Moderna exotic insider transaction detected
nasdaq News
over a week ago at www.macroaxis.com         
Moderna exotic insider transaction detected
Macroaxis News
over a week ago at www.fool.com         
Exercise or conversion by Andres Juan of 435 shares of Moderna subject to Rule 16b-3
fool News
over a week ago at seekingalpha.com         
Is Moderna Stock A Buy, Sell, Or Hold After Recent Earnings - Seeking Alpha
seekingalpha News
over two weeks ago at www.nasdaq.com         
Which COVID Vaccine Stock has a Better Shot at Generating Higher Returns - Nasdaq
nasdaq News
over two weeks ago at www.fool.com         
4 Bold Words From Modernas CEO That Could Be Worth Billions - The Motley Fool
fool News
over two weeks ago at www.macroaxis.com         
Moderna exotic insider transaction detected
Macroaxis News
over two weeks ago at www.macroaxis.com         
Exercise or conversion by Andres Juan of 2000 shares of Moderna subject to Rule 16b-3
Macroaxis News
over two weeks ago at www.barrons.com         
Exercise or conversion by Hoge Stephen of 10000 shares of Moderna subject to Rule 16b-3
Barrons News
over two weeks ago at www.gobankingrates.com         
Exercise or conversion by Afeyan Noubar of 703 shares of Moderna subject to Rule 16b-3
news
There is far too much social signal, news, headlines, and media speculation about Moderna that is available to investors today. That information is available publicly through Moderna media outlets and privately through word of mouth or via Moderna internal channels. However, regardless of the origin, that massive amount of Moderna data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Moderna news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Moderna relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Moderna's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Moderna alpha.

Moderna Performance against DOW

 Price Growth (%)  
      Timeline 
1
Exercise or conversion by Andres Juan of 14462 shares of Mod...03/02/2022
2
Exercise or conversion by Hoge Stephen of 10000 shares of Mo...03/04/2022
3
Moderna exotic insider transaction detected03/11/2022
4
Exercise or conversion by Andres Juan of 2000 shares of Mode...03/18/2022
5
Exercise or conversion by Andres Juan of 2000 shares of Mode...03/25/2022
6
EPS Estimate03/31/2022
7
Exercise or conversion by Andres Juan of 2000 shares of Mode...04/01/2022
8
Exercise or conversion by Hoge Stephen of 10000 shares of Mo...04/05/2022
9
Bona fide gift to Bancel Stephane of 4000 shares of Moderna ...04/06/2022
10
Exercise or conversion by Andres Juan of 2000 shares of Mode...04/08/2022
11
Financial Statements04/11/2022
12
Exercise or conversion by Andres Juan of 2000 shares of Mode...04/12/2022
13
Exercise or conversion by Hoge Stephen of 10000 shares of Mo...04/14/2022
14
Why BioNTech, Moderna, and Novavax Stocks Are Sinking Today ...04/18/2022
15
Moderna exotic insider transaction detected04/22/2022
16
Sale by Hoge Stephen of 1486 shares of Moderna04/25/2022
17
Sale by Hoge Stephen of 1051 shares of Moderna04/26/2022
18
Moderna exotic insider transaction detected04/29/2022
19
Filing05/03/2022
20
EPS Reported05/04/2022
21
Exercise or conversion by Andres Juan of 2000 shares of Mode...05/06/2022
22
Which COVID Vaccine Stock has a Better Shot at Generating Hi...05/09/2022
23
Filing05/11/2022
24
Moderna exotic insider transaction detected05/12/2022
25
Financial Statements05/13/2022
26
Exercise or conversion by Hoge Stephen of 10000 shares of Mo...05/16/2022
27
Vaccine Stocks Pfizer, BioNTech Score A Win Leading Pfizer T...05/17/2022
28
Moderna exotic insider transaction detected05/18/2022
Additionally, see Moderna Hype Analysis, Moderna Correlation and Moderna Performance. Note that the Moderna information on this page should be used as a complementary analysis to other Moderna's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Moderna Stock analysis

When running Moderna price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Is Moderna's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine Moderna value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.